680 George Street
Level 12
Sydney, NSW 2000
Australia
61 2 8280 7355
https://www.elixinolwellness.com
Sektor(en): Healthcare
Branche: Drug Manufacturers - Specialty & Generic
Vollzeitmitarbeiter:
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Mr. Ronald Dufficy BEC, FCPA | Group CEO and MD | 266,17k | N/A | N/A |
Ms. Josephine Lorenz | Global CFO & Joint Company Secretary | 202,2k | N/A | N/A |
Glen Zurcher | Account Director of Investor Relations Department | N/A | N/A | N/A |
Ms. Natalie Butler | Head of Marketing & Executive Director | N/A | N/A | N/A |
Ms. Sarah Prince ACIS, BA, GrdDipCorpGov, LLB | Joint Company Secretary | N/A | N/A | N/A |
Elixinol Wellness Limited, through its subsidiaries, engages in the manufacture and distribution of hemp derived nutraceuticals, skincare, and food products in the Americas, Europe, and Australia. It offers hemp derived cannabidiol and food products, dietary supplements, topicals, and skincare products. The company was formerly known as Elixinol Global Limited and changed its name to Elixinol Wellness Limited in May 2021. The company was incorporated in 2017 and is headquartered in Sydney, Australia.
Elixinol Wellness Limiteds ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.